Literature DB >> 16206116

In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of M. genitalium-positive nongonococcal urethritis in men.

M Yasuda1, S Maeda, T Deguchi.   

Abstract

We investigated the minimum inhibitory concentrations of some fluoroquinolones for Mycoplasma genitalium and their bacteriological efficacy in the treatment of M. genitalium-positive nongonococcal urethritis. In vitro, levofloxacin was less active than gatifloxacin, tosufloxacin, and sparfloxacin. In vivo, the bacteriological efficacy of gatifloxacin was superior to that of levofloxacin or tosufloxacin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16206116     DOI: 10.1086/496983

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Mycoplasma genitalium: should we treat and how?

Authors:  Lisa E Manhart; Jennifer M Broad; Matthew R Golden
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

2.  Azithromycin failure in Mycoplasma genitalium urethritis.

Authors:  Catriona S Bradshaw; Jorgen S Jensen; Sepehr N Tabrizi; Timothy R H Read; Suzanne M Garland; Carol A Hopkins; Lorna M Moss; Christopher K Fairley
Journal:  Emerg Infect Dis       Date:  2006-07       Impact factor: 6.883

Review 3.  Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations.

Authors:  Deborah L Couldwell; David A Lewis
Journal:  Infect Drug Resist       Date:  2015-05-26       Impact factor: 4.003

4.  Multidrug-resistant Mycoplasma genitalium infections in Europe.

Authors:  J F Braam; L van Dommelen; C J M Henquet; J H B van de Bovenkamp; J G Kusters
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-30       Impact factor: 3.267

5.  Persistence of Mycoplasma genitalium following azithromycin therapy.

Authors:  Catriona S Bradshaw; Marcus Y Chen; Christopher K Fairley
Journal:  PLoS One       Date:  2008-11-03       Impact factor: 3.240

Review 6.  Management of Mycoplasma genitalium infections - can we hit a moving target?

Authors:  Jørgen Skov Jensen; Catriona Bradshaw
Journal:  BMC Infect Dis       Date:  2015-08-19       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.